Exciting medical research breakthroughs and tips for VTE management, risk assessment and prevention.
A/Prof. Hitos: Exciting Medical Research Breakthroughs in Australia
LMWH: low molecular weight heparin VTE = venous thromboembolism.
1 Clexane Australian Product Information, 13 July 2018.
2 Fareed J et al. Semin Thromb Hemost 2004;30:706–13.
Date of preparation: August 2019. SM_SAN980. SAANZ.ENO.19.01.0069c
*Clexane Safety Lock as an automatic safety lock system.
Further information is available on request from Sanofi.
sanofi-aventis australia pty ltd training as Sanofi, ABN 31 008 558 807, Talavera Corporate Centre, Building D, 12-24 Talavera Road, Macquarie Park, NSW 2113. ®Clexane is a registered trademark of sanofi-aventis.
Clexane Safety Lock Webinars
Training on how to use Clexane Safety Lock and other resources are available now.
Your patients' information portal for all VTE matters
Receive future issues of Anticoagulation Matters, curated specifically for you.
Access patient information and resources on VTE and Clexane®.